Q3 FY2026 · ended Sep 30, 2026 · Revenue $605.10M, -3.4% YoY · Filed Oct 29, 2026
Teladoc Health, Inc. (TDOC) files with the SEC under industry code 8011, Services-Offices & Clinics of Doctors of Medicine. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $605.1 million and a net loss of $26.9 million. Free cash flow was $105.2 million. As of Sep 30, 2026 it held $849.9 million in cash and investments and $37.6 million in total debt.
Company profile
- Industry
- Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
- Listed as
- TDOC (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1477449
- Former names
- Teladoc, Inc. (until Aug 1, 2018)
Other Services-Offices & Clinics of Doctors of Medicine companies
- Hims & Hers Health, Inc. HIMS
- Starling Oncology, Inc. STLN
- SBC Medical Group Holdings Inc SBC
- Auna S.A. AUNA
- Airsculpt Technologies, Inc. AIRS
- LifeMD, Inc. LFMD
- Westin Acquisition Corp WSTN
- Basel Medical Group Ltd BMGL
All 12 Services-Offices & Clinics of Doctors of Medicine companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $605.1M | $606.9M | $613.8M | $642.3M | $626.4M |
| Operating income | -$28.1M | -$37.1M | -$61.8M | -$36.0M | -$52.0M |
| Net income | -$26.9M | -$38.9M | -$63.8M | -$25.1M | -$49.5M |
| Diluted EPS | -$0.15 | -$0.21 | -$0.36 | -$0.14 | -$0.28 |
| Operating cash flow | $106.5M | $64.7M | $9.5M | $87.7M | $99.3M |
| Free cash flow | $105.2M | $63.7M | $7.9M | $85.1M | $97.0M |
| Total assets | $2.8B | $2.8B | $2.8B | $2.9B | $2.9B |
| Total liabilities | $1.5B | $1.4B | $1.5B | $1.5B | $1.5B |
| Stockholders' equity | $1.3B | $1.3B | $1.3B | $1.4B | $1.4B |
| Cash and investments | $849.9M | $774.3M | $750.7M | $781.1M | $726.2M |
| Total debt | $37.6M | $39.5M | $42.2M | $45.2M | $48.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 25, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 31, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 13, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 3, 2026 | Aug 3, 2026 |
All 1000 Teladoc Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.